[68Ga]Ga-FAPI-04 PET与MRI-DWI辅助卵巢癌肿瘤减灭术的手术循证比较
本研究纳入36例疑似或确诊卵巢癌患者行[68Ga]Ga-FAPI-04 PET/MRI,其中19例接受减灭术者用于诊断效能分析。[68Ga]Ga-FAPI-04 PET检测腹盆腔转移的灵敏度76.8%高于MRI-DWI的59.9%,准确率84.9%高于80.7%,漏诊率23.2%低于40.1%。[68Ga]Ga-FAPI-04 PET改变了42%基于MRI-DWI制定的手术规划。
要点
- [68Ga]Ga-FAPI-04 PET检测腹盆腔转移灵敏度76.8%、准确率84.9%,均高于MRI-DWI。
- PET诊断优势在初次减灭术患者中更明显,在间隔减灭术患者中减弱。
- [68Ga]Ga-FAPI-04 PET改变了42%既往基于MRI-DWI的手术规划。
核心结论
- [68Ga]Ga-FAPI-04 PET在辅助卵巢癌减灭术方面比MRI-DWI更有效。
- 整合[68Ga]Ga-FAPI-04 PET/MR成像是卵巢癌患者减灭术规划的潜在方法。
研究设计与样本
- 纳入36例疑似或确诊卵巢癌患者行整合[68Ga]Ga-FAPI-04 PET/MRI检查。
- 19例接受减灭术患者(III-IV期15例、I-II期4例)纳入诊断效能分析。
- 对转移灶行FAP免疫组化,研究[68Ga]Ga-FAPI-04 PET的影像学遗漏及其在初次减灭术与间隔减灭术患者中的不同表现。
- 在35例确诊卵巢癌患者中研究影像对治疗决策的潜在影响。
主要发现
- [68Ga]Ga-FAPI-04 PET检测腹盆腔转移灵敏度76.8% vs MRI-DWI 59.9%,准确率84.9% vs 80.7%,漏诊率23.2% vs 40.1%。
- [68Ga]Ga-FAPI-04 PET在70.8%(17/24)腹盆腔区域优于MRI-DWI,其中含7个影响可切除性与手术复杂性的关键区域。
- MRI-DWI在膀胱腹膜面和膈肌中心腱处占优势。
- 两种方法判断矛盾时(14.9%),[68Ga]Ga-FAPI-04 PET正确识别更多病灶,尤其在初次减灭术患者中(73.8%)。
- FAP表达与病灶大小无关,且在间隔减灭术患者中降低。
临床怎么用
- [68Ga]Ga-FAPI-04 PET在辅助卵巢癌减灭术方面比MRI-DWI更有效。
- 整合[68Ga]Ga-FAPI-04 PET/MR成像是卵巢癌患者减灭术规划的潜在方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Imaging assessment of abdominopelvic tumor burden is crucial for debulking surgery decision in ovarian cancer patients. This study aims to compare the efficiency of [68Ga]Ga-FAPI-04 FAPI PET and MRI-DWI in the preoperative evaluation and its potential impact to debulking surgery decision. METHODS: Thirty-six patients with suspected/confirmed ovarian cancer were enrolled and underwent integrated [68Ga]Ga-FAPI-04 PET/MRI. Nineteen patients (15 stage III-IV and 4 I-II stage) who underwent debulking surgery were involved in the diagnostic efficiency analysis. The images of [68Ga]Ga-FAPI-04 PET and MRI-DWI were visually analyzed respectively. Immunohistochemistry on FAP was performed in metastatic lesions to investigate the radiological missing of [68Ga]Ga-FAPI-04 PET as well as its different performance in primary debulking surgery (PDS) and interval debulking surgery (IDS) patients. Potential imaging impact on management was also studied in 35 confirmed ovarian cancer patients. RESULTS: [68Ga]Ga-FAPI-04 PET displayed higher sensitivity (76.8% vs.59.9%), higher accuracy (84.9% vs. 80.7%), and lower missing rate (23.2% vs. 40.1%) than MRI-DWI in detecting abdominopelvic metastasis. The diagnostic superiority of [68Ga]Ga-FAPI-04 PET is more obvious in PDS patients but diminished in IDS patients. [68Ga]Ga-FAPI-04 PET outperformed MRI-DWI in 70.8% abdominopelvic regions (17/24), which contained seven key regions that impact the resectability and surgical complexity. MRI-DWI hold advantage in the peritoneal surface of the bladder and the central tendon of the diaphragm. Of the contradictory judgments between the two modalities (14.9%), [68Ga]Ga-FAPI-04 PET correctly identified more lesions, particularly in PDS patients (73.8%). In addition, FAP expression was independent of lesion size and decreased in IDS patients. [68Ga]Ga-FAPI-04 PET changed 42% of surgical planning that was previously based on MRI-DWI. CONCLUSION: [68Ga]Ga-FAPI-04 PET is more efficient in assisting debulking surgery in ovarian cancer patients than MRI-DWI. Integrated [68Ga]Ga-FAPI-04 PET/MR imaging is a potential method for planning debulking surgery in ovarian cancer patients.
引用
- Li X, Lv X, Quan Z, et al. Surgical evidence-based comparison of [68Ga]Ga-FAPI-04 PET and MRI-DWI for assisting debulking surgery in ovarian cancer patients. Eur J Nucl Med Mol Imaging. 2024. PMID: 38197954. doi:10.1007/s00259-023-06582-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。